Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates
Amgen (AMGN) came out with quarterly earnings of $5.15 per share, beating the Zacks Consensus Estima…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
+2.5% vs SMA 50 · +17.4% vs SMA 200
Momentum
Distribution pattern detected. More selling days than accumulation over the past 20 sessions. Not a conducive environment for a squeeze.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $270.8B $253.9B–$292.4B | — | $6.38 | — | ±3% | High10 |
FY2026(current) | $325.1B $248.8B–$382.9B | ▲ +20.0% | $9.81 | ▲ +53.7% | ±44% | High12 |
FY2027 | $303.1B $255.3B–$354.5B | ▼ -6.8% | $9.22 | ▼ -6.0% | ±29% | High12 |
Dividend per payment — last 8 periods
Amgen (AMGN) came out with quarterly earnings of $5.15 per share, beating the Zacks Consensus Estima…

Shell plc is a British multinational oil and gas company headquartered in London, England. Shell is a public limited company with a primary listing on the London Stock Exchange and secondary listings on Euronext Amsterdam and the New York Stock Exchange.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
SHEL◀ | $90.67 | +1.51% | $251.7B | 14.2 | -591.0% | 668.4% | 1500 |
| $396.06 | +0.42% | $2.0T | 29.3 | +3296.8% | 4510.0% | 1500 | |
| $91.86 | -0.77% | $309.3B | 13.7 | +318.8% | 1510.7% | 1500 | |
| $131.91 | -0.31% | $302.8B | 23.4 | +586.3% | 1305.9% | 1500 | |
| $187.37 | -0.82% | $287.1B | 27.6 | +862.9% | 1745.9% | 1500 | |
| $147.85 | -1.76% | $272.7B | 20.3 | +597.3% | 2564.4% | 1500 | |
| $192.62 | -0.89% | $249.3B | 10.7 | +652.3% | 992.0% | 1500 | |
| Sector avg | — | -0.37% | — | 19.9 | +817.6% | 1899.6% | 1500 |